Jelmyto Sales: $20.3 million in Q1 2025, 8% year-over-year growth. Revenue Growth: Driven by 12% underlying demand growth. R&D Expenses: $19.9 million in Q1 2025, up from $15.5 million in Q1 2024. SG&A Expenses: $35 million in Q1 2025, up from $27.3 million in Q1 2024. Net Loss: $43.8 million or $0.92 per share in